Altered platelet functions during treatment with apremilast for psoriatic arthritis: A case report

Curr Res Transl Med. 2022 Sep;70(4):103358. doi: 10.1016/j.retram.2022.103358. Epub 2022 Jun 17.

Authors

Gerasimos Tsilimidos¹, Sabine Blum², Alessandro Aliotta², Alexandre Dumusc³, Lorenzo Alberio²

Affiliations

¹ Service and Central Laboratory of Hematology, Lausanne University Hospital (CHUV) and UNIL, Lausanne, Switzerland.. Electronic address: Gerasimos.tsilimidos@chuv.ch.
² Service and Central Laboratory of Hematology, Lausanne University Hospital (CHUV) and UNIL, Lausanne, Switzerland.
³ Department of Rheumatology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

PMID: 35724504
DOI: 10.1016/j.retram.2022.103358

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Arthritis, Psoriatic* / drug therapy
Humans
Thalidomide / adverse effects
Treatment Outcome

Substances

apremilast
Thalidomide